387 related articles for article (PubMed ID: 32287586)
41. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.
Kong WP; Xu L; Stadler K; Ulmer JB; Abrignani S; Rappuoli R; Nabel GJ
J Virol; 2005 Nov; 79(22):13915-23. PubMed ID: 16254327
[TBL] [Abstract][Full Text] [Related]
42. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
[TBL] [Abstract][Full Text] [Related]
43. Virology. What links bats to emerging infectious diseases?
Dobson AP
Science; 2005 Oct; 310(5748):628-9. PubMed ID: 16254175
[No Abstract] [Full Text] [Related]
44. Expression library immunization: a road map for discovery of vaccines against infectious diseases.
Talaat AM; Stemke-Hale K
Infect Immun; 2005 Nov; 73(11):7089-98. PubMed ID: 16239502
[No Abstract] [Full Text] [Related]
45. Orchitis: a complication of severe acute respiratory syndrome (SARS).
Xu J; Qi L; Chi X; Yang J; Wei X; Gong E; Peh S; Gu J
Biol Reprod; 2006 Feb; 74(2):410-6. PubMed ID: 16237152
[TBL] [Abstract][Full Text] [Related]
46. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors.
Hui DS; Wong KT; Ko FW; Tam LS; Chan DP; Woo J; Sung JJ
Chest; 2005 Oct; 128(4):2247-61. PubMed ID: 16236881
[TBL] [Abstract][Full Text] [Related]
47. Molecular epidemiology of SARS-associated coronavirus, Beijing.
Liu W; Tang F; Fontanet A; Zhan L; Wang TB; Zhang PH; Luan YH; Cao CY; Zhao QM; Wu XM; Xin ZT; Zuo SQ; Baril L; Vabret A; Shao YM; Yang H; Cao WC
Emerg Infect Dis; 2005 Sep; 11(9):1420-4. PubMed ID: 16229772
[TBL] [Abstract][Full Text] [Related]
48. A simple and rapid approach for screening of SARS-coronavirus genotypes: an evaluation study.
Chung GT; Chiu RW; Cheung JL; Jin Y; Chim SS; Chan PK; Lo YM
BMC Infect Dis; 2005 Oct; 5():87. PubMed ID: 16229749
[TBL] [Abstract][Full Text] [Related]
49. Modular organization of SARS coronavirus nucleocapsid protein.
Chang CK; Sue SC; Yu TH; Hsieh CM; Tsai CK; Chiang YC; Lee SJ; Hsiao HH; Wu WJ; Chang WL; Lin CH; Huang TH
J Biomed Sci; 2006 Jan; 13(1):59-72. PubMed ID: 16228284
[TBL] [Abstract][Full Text] [Related]
50. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer.
Zhai Y; Sun F; Li X; Pang H; Xu X; Bartlam M; Rao Z
Nat Struct Mol Biol; 2005 Nov; 12(11):980-6. PubMed ID: 16228002
[TBL] [Abstract][Full Text] [Related]
51. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells.
Ziegler T; Matikainen S; Rönkkö E; Osterlund P; Sillanpää M; Sirén J; Fagerlund R; Immonen M; Melén K; Julkunen I
J Virol; 2005 Nov; 79(21):13800-5. PubMed ID: 16227300
[TBL] [Abstract][Full Text] [Related]
52. The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication.
Graham RL; Sims AC; Brockway SM; Baric RS; Denison MR
J Virol; 2005 Nov; 79(21):13399-411. PubMed ID: 16227261
[TBL] [Abstract][Full Text] [Related]
53. Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases.
Wang Y; Sun S; Shen H; Jiang L; Zhang M; Xiao D; Liu Y; Ma X; Zhang Y; Guo N; Jia T
Cell Mol Immunol; 2004 Aug; 1(4):304-7. PubMed ID: 16225774
[TBL] [Abstract][Full Text] [Related]
54. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
Lee TW; Cherney MM; Huitema C; Liu J; James KE; Powers JC; Eltis LD; James MN
J Mol Biol; 2005 Nov; 353(5):1137-51. PubMed ID: 16219322
[TBL] [Abstract][Full Text] [Related]
55. Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor.
Martina E; Stiefl N; Degel B; Schulz F; Breuning A; Schiller M; Vicik R; Baumann K; Ziebuhr J; Schirmeister T
Bioorg Med Chem Lett; 2005 Dec; 15(24):5365-9. PubMed ID: 16216498
[TBL] [Abstract][Full Text] [Related]
56. Mutational analysis of the SARS virus Nsp15 endoribonuclease: identification of residues affecting hexamer formation.
Guarino LA; Bhardwaj K; Dong W; Sun J; Holzenburg A; Kao C
J Mol Biol; 2005 Nov; 353(5):1106-17. PubMed ID: 16216269
[TBL] [Abstract][Full Text] [Related]
57. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
Spruth M; Kistner O; Savidis-Dacho H; Hitter E; Crowe B; Gerencer M; Brühl P; Grillberger L; Reiter M; Tauer C; Mundt W; Barrett PN
Vaccine; 2006 Jan; 24(5):652-61. PubMed ID: 16214268
[TBL] [Abstract][Full Text] [Related]
58. Understanding the spatial diffusion process of severe acute respiratory syndrome in Beijing.
Meng B; Wang J; Liu J; Wu J; Zhong E
Public Health; 2005 Dec; 119(12):1080-7. PubMed ID: 16214187
[TBL] [Abstract][Full Text] [Related]
59. Prediction of functional class of the SARS coronavirus proteins by a statistical learning method.
Cai CZ; Han LY; Chen X; Cao ZW; Chen YZ
J Proteome Res; 2005; 4(5):1855-62. PubMed ID: 16212442
[TBL] [Abstract][Full Text] [Related]
60. Virology. Researchers tie deadly SARS virus to bats.
Normile D
Science; 2005 Sep; 309(5744):2154-5. PubMed ID: 16195440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
